These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34175912)

  • 1. [Heart Team and heart valve diseases: the importance of a multidisciplinary approach].
    Malara S; Burzotta F; Romagnoli E; Aurigemma C; Bruno P; Pavone N; Graziani F; Trani C; Crea F; Massetti M
    G Ital Cardiol (Rome); 2021 Jul; 22(7):561-569. PubMed ID: 34175912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience.
    Burzotta F; Graziani F; Trani C; Aurigemma C; Bruno P; Lombardo A; Liuzzo G; Nesta M; Lanza GA; Romagnoli E; Locorotondo G; Leone AM; Pavone N; Spalletta C; Pelargonio G; Sanna T; Aspromonte N; Cavaliere F; Crea F; Massetti M
    J Am Heart Assoc; 2022 Jun; 11(11):e024404. PubMed ID: 35621200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart valve clinic: rationale and organization.
    Lancellotti P; Rosenhek R; Pibarot P
    Can J Cardiol; 2014 Sep; 30(9):1104-7. PubMed ID: 24841083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESC Working Group on Valvular Heart Disease position paper--heart valve clinics: organization, structure, and experiences.
    Lancellotti P; Rosenhek R; Pibarot P; Iung B; Otto CM; Tornos P; Donal E; Prendergast B; Magne J; La Canna G; Piérard LA; Maurer G
    Eur Heart J; 2013 Jun; 34(21):1597-606. PubMed ID: 23293304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.
    Rosenhek R; Iung B; Tornos P; Antunes MJ; Prendergast BD; Otto CM; Kappetein AP; Stepinska J; Kaden JJ; Naber CK; Acartürk E; Gohlke-Bärwolf C
    Eur Heart J; 2012 Apr; 33(7):822-8, 828a, 828b. PubMed ID: 21406443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EDUCATIONAL SERIES ON THE SPECIALIST VALVE CLINIC: Challenges in the diagnosis and management of valve disease: the case for the specialist valve clinic.
    Messika-Zeitoun D; Burwash IG; Mesana T
    Echo Res Pract; 2019 Dec; 6(4):T1-T6. PubMed ID: 31729210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued expansion of the Heart Team concept.
    Passeri JJ; Melnitchouk S; Palacios IF; Sundt TM
    Future Cardiol; 2015 Mar; 11(2):219-28. PubMed ID: 25760880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation　- The Fushimi AF Registry.
    Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M;
    Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart team approach in treatment of mitral regurgitation: patient selection and outcome.
    Külling M; Corti R; Noll G; Küest S; Hürlimann D; Wyss C; Reho I; Tanner FC; Külling J; Meinshausen N; Gaemperli O; Wenaweser P; Salzberg SP; Aymard T; Grünenfelder J; Biaggi P
    Open Heart; 2020 Jul; 7(2):. PubMed ID: 32690553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
    Grube E; Sinning JM; Vahanian A
    Eur Heart J; 2014 Feb; 35(8):490-5. PubMed ID: 24385378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priorities for Patient-Centered Research in Valvular Heart Disease: A Report From the National Heart, Lung, and Blood Institute Working Group.
    Lindman BR; Arnold SV; Bagur R; Clarke L; Coylewright M; Evans F; Hung J; Lauck SB; Peschin S; Sachdev V; Tate LM; Wasfy JH; Otto CM
    J Am Heart Assoc; 2020 May; 9(9):e015975. PubMed ID: 32326818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidisciplinary Heart Team Approach for Complex Coronary Artery Disease: Single Center Clinical Presentation.
    Young MN; Kolte D; Cadigan ME; Laikhter E; Sinclair K; Pomerantsev E; Fifer MA; Sundt TM; Yeh RW; Jaffer FA
    J Am Heart Assoc; 2020 Apr; 9(8):e014738. PubMed ID: 32308096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmet needs in valvular heart disease.
    Messika-Zeitoun D; Baumgartner H; Burwash IG; Vahanian A; Bax J; Pibarot P; Chan V; Leon M; Enriquez-Sarano M; Mesana T; Iung B
    Eur Heart J; 2023 Jun; 44(21):1862-1873. PubMed ID: 36924203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantation.
    Osnabrugge RL; Speir AM; Head SJ; Fonner CE; Fonner E; Kappetein AP; Rich JB
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):400-8; discussion 408. PubMed ID: 24574449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valvular Heart Disease Epidemics.
    Domenech B; Pomar JL; Prat-González S; Vidal B; López-Soto A; Castella M; Sitges M
    J Heart Valve Dis; 2016 Jan; 25(1):1-7. PubMed ID: 29505225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
    Coffey S; Cox B; Williams MJ
    Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of valvular heart disease assessment and therapy.
    Sengupta PP; Kluin J; Lee SP; Oh JK; Smits AIPM
    Lancet; 2024 Apr; 403(10436):1590-1602. PubMed ID: 38554727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.